Hair Isotope Analysis for Early Cancer Detection
Launched by UNIVERSITY OF READING · May 27, 2025
Trial Information
Current as of August 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating a new way to detect cancer early by analyzing hair samples. Researchers believe that cancer can change the way our bodies process nutrients, and these changes might be visible in the hair we grow. By examining a small strand of hair from people diagnosed with cancer, the study aims to find early signs of the disease. This method is non-invasive, meaning it doesn’t require any medical procedures, making it easier for patients to participate.
To be eligible for this trial, participants must have a cancer diagnosis and provide a sufficient amount of hair. The study is open to people of all genders aged 65 to 74. If you decide to participate, you will simply donate a small amount of hair, which will be analyzed in a laboratory using a technique called Isotope Ratio Mass Spectrometry (IRMS). This research could help develop new, easier ways to screen for cancer early, potentially improving treatment outcomes for patients. The trial is not yet recruiting, so there will be more information available soon.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Cancer diagnosis, sufficient hair
- Exclusion Criteria:
- • -
About University Of Reading
The University of Reading is a prestigious research institution in the United Kingdom, renowned for its commitment to advancing knowledge across various disciplines, including health sciences. As a clinical trial sponsor, the university leverages its cutting-edge research facilities and interdisciplinary expertise to conduct innovative studies aimed at improving healthcare outcomes. With a strong emphasis on ethical research practices and collaboration with industry partners, the University of Reading strives to contribute valuable insights to the field of medicine, fostering the development of new treatments and interventions that address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Reading, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported